Astellas Ireland Co Ltd

General

Total Cases12

Active Cases--

Patents--

CourtsD. Delaware

TypeOperating Company

Elite Ratings

PTAB

--

--

--

Ratings

Experience

Grade

Trend

DCT

L3

A

PTAB

L4

A

CAFC

L3

D

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered	Case	Description
06/19/20	Astellas Pharma Inc v. Actavis Elizabeth LLC 1:16-CV-00905 ( D. DE )	REDACTED VERSION of 588 Letter by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Silver, Daniel) (Entered: 06/19/2020)
06/17/20	Astellas Pharma Inc v. Actavis Elizabeth LLC 1:16-CV-00905 ( D. DE )	ORAL ORDER: The Court, having reviewed the June 15, 2020 letter regarding the action that remains pending between Astellas Pharma Inc., et al. ("Astellas") and Defendant Sandoz Inc. ("Sandoz"), (D.I. 588), hereby ORDERS that if the parties have not resolved their dispute by July 17, 2020, Astellas and Sandoz shall submit a joint revised proposed Scheduling Order (that is consistent Judge Burke's form Rule 16 Scheduling Order Patent, which can be found on Judge Burke's portion of the District Court's website, for the remaining portions of the case), along with a joint letter of no more than 3 single-spaced pages summarizing the parties' positions as to any disputes relating to that Order. Ordered by Judge Christopher J. Burke on 6/17/2020. (dlb) (Entered: 06/17/2020) ORAL ORDER: The Court, having reviewed the June 15, 2020 letter regarding the action that remains pending between Astellas Pharma Inc., et al. ("Astellas") and Defendant Sandoz Inc. ("Sandoz"), (D.I. 588), hereby ORDERS that if the parties have not resolved their dispute by July 17, 2020, Astellas and Sandoz shall submit a joint revised proposed Scheduling Order (that is consistent Judge Burke's form Rule 16 Scheduling Order Patent, which can be found on Judge Burke's portion of the District Court's website, for the remaining portions of the case), along with a joint letter of no more than 3 single-spaced pages summarizing the parties' positions as to any disputes relating to that Order. Ordered by Judge Christopher J. Burke on 6/17/2020. (dlb) (Entered: 06/17/2020)
06/15/20	Astellas Pharma Inc v. Actavis Elizabeth LLC 1:16-CV-00905 ( D. DE )	[SEALED] Letter to The Honorable Christopher J. Burke from Daniel M. Silver, Esq. regarding Status Report. (Attachments: # 1 Certificate of Service)(Silver, Daniel) (Entered: 06/15/2020)
06/15/20	Astellas Pharma Inc v. Actavis Elizabeth LLC 1:16-CV-00905 ( D. DE )	[SEALED] Letter to The Honorable Christopher J. Burke from Daniel M. Silver, Esq. regarding Status Report. (Attachments: # 1 Certificate of Service)(Silver, Daniel) (Entered: 06/15/2020)
05/14/20	Astellas Pharma Inc v. Actavis Elizabeth LLC 1:16-CV-00905 ( D. DE )	ORDER OF DISMISSAL WITHOUT PREJUDICE. Signed by Judge Joseph F. Bataillon on 5/13/2020. (nmg) (Entered: 05/14/2020)
05/14/20	Astellas Pharma Inc v. Actavis Elizabeth LLC 1:16-CV-00905 ( D. DE )	ORDER OF DISMISSAL WITHOUT PREJUDICE. Signed by Judge Joseph F. Bataillon on 5/13/2020. (nmg) (Entered: 05/14/2020)
05/08/20	Astellas Pharma Inc v. Actavis Elizabeth LLC 1:16-CV-00905 ( D. DE )	STIPULATION of Dismissal Without Prejudice by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Silver, Daniel) (Entered: 05/08/2020)
05/08/20	Astellas Pharma Inc v. Actavis Elizabeth LLC 1:16-CV-00905 ( D. DE )	STIPULATION of Dismissal Without Prejudice by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Silver, Daniel) (Entered: 05/08/2020)
05/07/20	Astellas Pharma Inc v. Actavis Elizabeth LLC 1:16-CV-00905 ( D. DE )	ORDER OF DISMISSAL WITHOUT PREJUDICE re 584 Stipulation of Dismissal. Pursuant to a Settlement and License Agreement, all claims and counterclaims between the Parties in Civil Action No. 16-cv-930, related to United States Patent Nos. 7,342,117; 7,982,049; 8,835,474; and RE44,872 (collectively Patents-in-suit) are dismissed, without prejudice. Each Party will bear its own costs and attorneys fees. (D.I. 25 in CA 16-930). Signed by Judge Joseph F. Bataillon on 5/7/2020. (lak) (Entered: 05/07/2020) ORDER OF DISMISSAL WITHOUT PREJUDICE re 584 Stipulation of Dismissal. Pursuant to a Settlement and License Agreement, all claims and counterclaims between the Parties in Civil Action No. 16-cv-930, related to United States Patent Nos. 7,342,117; 7,982,049; 8,835,474; and RE44,872 (collectively Patents-in-suit) are dismissed, without prejudice. Each Party will bear its own costs and attorneys fees. (D.I. 25 in CA 16-930). Signed by Judge Joseph F. Bataillon on 5/7/2020. (lak) (Entered: 05/07/2020)
05/07/20	Astellas Pharma Inc v. Windlas Healthcare Pvt Ltd 1:16-CV-00930 ( D. DE )	ORDER OF DISMISSAL WITHOUT PREJUDICE. Pursuant to a Settlement and License Agreement, all claims and counterclaims between the Parties in Civil Action No. 16-cv-930, related to United States Patent Nos. 7,342,117; 7,982,049; 8,835,474; and RE44,872 (collectively Patents-in-suit) are dismissed, without prejudice. Each Party will bear its own costs and attorneys fees. See Order for further details. (copy to pltf.) (CASE CLOSED). Signed by Judge Joseph F. Bataillon on 5/7/2020. (lak) (Entered: 05/07/2020) ORDER OF DISMISSAL WITHOUT PREJUDICE. Pursuant to a Settlement and License Agreement, all claims and counterclaims between the Parties in Civil Action No. 16-cv-930, related to United States Patent Nos. 7,342,117; 7,982,049; 8,835,474; and RE44,872 (collectively Patents-in-suit) are dismissed, without prejudice. Each Party will bear its own costs and attorneys fees. See Order for further details. (copy to pltf.) (CASE CLOSED). Signed by Judge Joseph F. Bataillon on 5/7/2020. (lak) (Entered: 05/07/2020)